Entecavir

• Post Date:

  Feb 04,2015

• Expiry Date:

  Feb 04,2016

• Detailed Description:

  Cas No. :142217-69-4 Product name: Entecavir
  CAS: 142217-69-4
  Molecular formula: C12H15N5O3
  Molecular weight: 277.283
  Description: Entecavir, abbreviated ETV, is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade names Baraclude (BMS), Entaco (Ranbaxy) and Entaliv (DRL).
  Entecavir is a nucleoside analog[1] (more specifically, a guanosine analogue) that inhibits reverse transcription, DNA replication and transcription in the viral replication process. The drug's manufacturer claims that entecavir is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir).
  Entecavir was approved by the U.S.FDA in March 2005.

• CAS Registry Number:

  142217-69-4

• Synonyms:

  ;2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one;2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3,9-dihydro-6H-purin-6-one;2-amino-9-[(3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3,9-dihydro-6H-purin-6-one;2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one hydrate (1:1);entecavir Baraclude;

• Molecular Formula:

  C₁₂H₁₅N₅O₃

• Molecular Weight:

  277.2792

• Molecular Structure:

  

• Company:

  AUSMAUCO BIOTECH CO., LIMITED     [ China ]        

• Contact:

  john

• Tel:

  +8618060810639

• Fax:

• Email:

  plantsale@aus-bio.com